Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Results from recent clinical trials have shown that GLP-1 receptor agonist medications are effective at lowering A1C and body weight.
Diabetes technology has come a long way over the years, and even more exciting developments seem to be right on the horizon; however, it’s important to be aware of the...
diaTribe is excited to bring you additional expanded coverage from the EASD 2021 virtual conference this past week! Find out more from leading clinicians and researchers...
A new procedure called DMR (duodenal mucosal resurfacing) is being studied in clinical trials to see if it can help people with type 2 diabetes improve their A1C without...
Studies show that if you have diabetes, increasing your Time in Range (TIR) can lower your risk of developing kidney disease. Learn how kidney disease is diagnosed, why...
A recent consensus report from leading experts details a new definition for what it means to have type 2 diabetes in remission and why it is important to use the proper...
Kerendia (also known as finerenone) can reduce the risk of heart attacks, hospitalization for heart failure, and cardiovascular death for adults with chronic kidney...
At the ADCES 2021 conference three diabetes care and education specialists gave their recommendations for how to craft an individual exercise routine and how to avoid...
A survey jointly conducted by diabetes research company dQ&A and The diaTribe Foundation assessed how well endocrinologists understood Time in Range and which...
Curious to know what apps are available to you to help you manage a variety of health conditions? At the ADCES 2021 conference, experts discussed the best options out...
When it comes to SGLT-2s and GLP-1s, there are several medicines available. Read below for more information on these therapies which have particular benefits for those...
The Association of Diabetes Care and Education Specialists 2021 conference covered the impacts of diabetes stigma, smart MDI therapies, insulin delivery by means other...
Social determinants of health describe the interaction between social, economic, and environmental factors and how they can influence a person’s health. Read below for...
An African-American who has spent his entire career in corporate America, Donald is now the president and chief executive officer of a non-profit organization that -...
July 15, 2015 In another disappointing turn, Diamyd Medical announced in late June that it was suspending a phase 3 trial for its GAD65 vaccine Diamyd. The US-based...
Dr. Jay Skyler weighs in on type 1 clinical trial design.
Learn about anti-CD3 therapy designed to slow or stop the progression of type 1 diabetes.
Dr. George Eisenbarth discusses the prevention of type 1 diabetes.
On July 29, the JDRF formally launched its innovative new online Clinical Trials Connection service. This service was launched to help patients with type 1 diabetes and...
Juvenile Diabetes Research Foundation President and CEO Dr. Alan Lewis discusses the organization's priorities, one year in.

Pages